A portrayal of E3 ubiquitin ligases and deubiquitylases in cancer

被引:43
|
作者
Satija, Yatendra Kumar [1 ]
Bhardwaj, Abhishek [1 ]
Das, Sanjeev [1 ]
机构
[1] Natl Inst Immunol, Mol Oncol Lab, New Delhi 110067, India
关键词
cancer; p53; ubiquitylation; proteasome; TUMOR-SUPPRESSOR GENE; CELL-CYCLE CONTROL; DEUBIQUITINATING ENZYME USP2A; FATTY-ACID SYNTHASE; RING-FINGER DOMAIN; DNA-DAMAGE; BETA-TRCP; MEDIATED DEGRADATION; PROSTATE-CANCER; PROTEIN LIGASE;
D O I
10.1002/ijc.28129
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
E3 ubiquitin ligases and deubiquitylating enzymes (DUBs) are the key components of ubiquitin proteasome system which plays a critical role in cellular protein homeostasis. Any shortcoming in their biological roles can lead to various diseases including cancer. The dynamic interplay between ubiquitylation and deubiquitylation determines the level and activity of several proteins including p53, which is crucial for cellular stress response and tumor suppression pathways. In this review, we describe the different types of E3 ubiquitin ligases including those targeting tumor suppressor p53, SCF ligases and RING type ligases and accentuate on biological functions of few important E3 ligases in the cellular regulatory networks. Tumor suppressor p53 level is tightly regulated by multiple E3 ligases including Mdm2, COP1, Pirh2, etc. SCF ubiquitin ligase complexes are key regulators of cell cycle and signal transduction. BRCA1 and VHL RING type ligases function as tumor suppressors and play an important role in DNA repair and hypoxia response respectively. Further, we discuss the biological consequences of deregulation of the E3 ligases and the implications for cancer development. We also describe deubiquitylases which reverse the process of ubiquitylation and regulate diverse cellular pathways including metabolism, cell cycle control and chromatin remodelling. As the E3 ubiquitin ligases and DUBs work in a substrate specific manner, an improved understanding of them can lead to better therapeutics for cancer.
引用
收藏
页码:2759 / 2768
页数:10
相关论文
共 50 条
  • [1] E3 ubiquitin ligases in cancer and implications for therapies
    Wang, Dong
    Ma, Leina
    Wang, Bin
    Liu, Jia
    Wei, Wenyi
    CANCER AND METASTASIS REVIEWS, 2017, 36 (04) : 683 - 702
  • [2] E3 ubiquitin ligases: styles, structures and functions
    Yang, Quan
    Zhao, Jinyao
    Chen, Dan
    Wang, Yang
    MOLECULAR BIOMEDICINE, 2021, 2 (01):
  • [3] HECT-Type E3 Ubiquitin Ligases in Cancer
    Bernassola, Francesca
    Chillemi, Giovanni
    Melino, Gerry
    TRENDS IN BIOCHEMICAL SCIENCES, 2019, 44 (12) : 1057 - 1075
  • [4] Regulation of apoptosis by E3 ubiquitin ligases in ubiquitin proteasome system
    Sharma, Akshay
    Trivedi, Arun K.
    CELL BIOLOGY INTERNATIONAL, 2020, 44 (03) : 721 - 734
  • [5] HECT E3 ubiquitin ligases - emerging insights into their biological roles and disease relevance
    Wang, Yaya
    Argiles-Castillo, Diana
    Kane, Emma, I
    Zhou, Anning
    Spratt, Donald E.
    JOURNAL OF CELL SCIENCE, 2020, 133 (07)
  • [6] Role of E3 ubiquitin ligases in gastric cancer
    Hou, Ya-Chao
    Deng, Jing-Yu
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (03) : 786 - 793
  • [7] E3 ubiquitin ligases in cancer and implications for therapies
    Dong Wang
    Leina Ma
    Bin Wang
    Jia Liu
    Wenyi Wei
    Cancer and Metastasis Reviews, 2017, 36 : 683 - 702
  • [8] Role of E3 ubiquitin ligases in gastric cancer
    Ya-Chao Hou
    Jing-Yu Deng
    World Journal of Gastroenterology, 2015, (03) : 786 - 793
  • [9] The SCF-type E3 Ubiquitin Ligases as Cancer Targets
    Kitagawa, Kyoko
    Kitagawa, Masatoshi
    CURRENT CANCER DRUG TARGETS, 2016, 16 (02) : 119 - 129
  • [10] The roles of E3 ubiquitin ligases in cancer progression and targeted therapy
    Sampson, Chibuzo
    Wang, Qiuping
    Otkur, Wuxiyar
    Zhao, Haifeng
    Lu, Yun
    Liu, Xiaolong
    Piao, Hai-long
    CLINICAL AND TRANSLATIONAL MEDICINE, 2023, 13 (03):